34 related articles for article (PubMed ID: 2542277)
1. Ordered opening of LDL receptor binding domain of human apolipoprotein E3 revealed by hydrogen/deuterium exchange mass spectrometry and fluorescence spectroscopy.
Yang L; Hernandez RV; Tran TN; Nirudodhi S; Beck WHJ; Maier CS; Narayanaswami V
Biochim Biophys Acta Proteins Proteom; 2018 Nov; 1866(11):1165-1173. PubMed ID: 30282614
[TBL] [Abstract][Full Text] [Related]
2. apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.
Fotakis P; Vezeridis A; Dafnis I; Chroni A; Kardassis D; Zannis VI
J Lipid Res; 2014 Jul; 55(7):1310-23. PubMed ID: 24776540
[TBL] [Abstract][Full Text] [Related]
3. Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.
Vezeridis AM; Drosatos K; Zannis VI
J Lipid Res; 2011 Jan; 52(1):45-56. PubMed ID: 20861163
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E: from lipid transport to neurobiology.
Hauser PS; Narayanaswami V; Ryan RO
Prog Lipid Res; 2011 Jan; 50(1):62-74. PubMed ID: 20854843
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
Leroy A; Landrieu I; Huvent I; Legrand D; Codeville B; Wieruszeski JM; Lippens G
J Biol Chem; 2010 Oct; 285(43):33435-33444. PubMed ID: 20679343
[TBL] [Abstract][Full Text] [Related]
6. Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E.
Guttman M; Prieto JH; Croy JE; Komives EA
Biochemistry; 2010 Feb; 49(6):1207-16. PubMed ID: 20030366
[TBL] [Abstract][Full Text] [Related]
7. A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity.
Sivashanmugam A; Wang J
J Biol Chem; 2009 May; 284(21):14657-66. PubMed ID: 19307174
[TBL] [Abstract][Full Text] [Related]
8. The key role of apolipoprotein E in atherosclerosis.
Greenow K; Pearce NJ; Ramji DP
J Mol Med (Berl); 2005 May; 83(5):329-42. PubMed ID: 15827760
[TBL] [Abstract][Full Text] [Related]
9. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
Chou CY; Lin YL; Huang YC; Sheu SY; Lin TH; Tsay HJ; Chang GG; Shiao MS
Biophys J; 2005 Jan; 88(1):455-66. PubMed ID: 15475580
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
[TBL] [Abstract][Full Text] [Related]
11. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity TL; Friedlander EJ; Rall SC; Weisgraber KH; Mahley RW
J Biol Chem; 1983 Oct; 258(20):12341-7. PubMed ID: 6313652
[TBL] [Abstract][Full Text] [Related]
12. [Human apolipoprotein E: polymorphism and binding domain of the receptors].
Bekaert ED; Ayrault-Jarrier M; Polonovski J
Biochimie; 1986 May; 68(5):629-37. PubMed ID: 3015256
[TBL] [Abstract][Full Text] [Related]
13. Receptor interactions controlling lipoprotein metabolism.
Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
Can J Biochem Cell Biol; 1985 Aug; 63(8):898-905. PubMed ID: 2998579
[TBL] [Abstract][Full Text] [Related]
14. Human apolipoprotein E. Receptor binding activity of truncated variants with carboxyl-terminal deletions.
Lalazar A; Mahley RW
J Biol Chem; 1989 May; 264(15):8447-50. PubMed ID: 2542277
[TBL] [Abstract][Full Text] [Related]
15. The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity.
Dong LM; Innerarity TL; Arnold KS; Newhouse YM; Weisgraber KH
J Lipid Res; 1998 Jun; 39(6):1173-80. PubMed ID: 9643348
[TBL] [Abstract][Full Text] [Related]
16. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.
Lalazar A; Weisgraber KH; Rall SC; Giladi H; Innerarity TL; Levanon AZ; Boyles JK; Amit B; Gorecki M; Mahley RW
J Biol Chem; 1988 Mar; 263(8):3542-5. PubMed ID: 2831187
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
